Horizon Therapeutics Public Ltd Co

MACQUARIE GROUP LTD

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

7,801

Value ($000)

902

Weight

0.0%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	902	0.0%	7,801	9/30/2023
2023 Q2	10/27/2023	623	0.0%	6,057	6/30/2023
2023 Q1	6/1/2023	964	0.0%	8,829	3/31/2023
2022 Q4	2/21/2023	10,073	0.0%	88,514	12/31/2022
2022 Q3	11/14/2022	111,870	0.1%	1,807,564	9/30/2022
2022 Q2	8/17/2022	147,765	0.2%	1,852,618	6/30/2022
2022 Q1	5/16/2022	203,820	0.2%	1,937,267	3/31/2022
2021 Q4	2/11/2022	189,541	0.2%	1,758,913	12/31/2021
2021 Q3	11/12/2021	178,119	0.2%	1,626,071	9/30/2021
2021 Q2	8/13/2021	147,109	0.1%	1,571,013	6/30/2021
2021 Q1	5/14/2021	872	0.0%	9,467	3/31/2021
2020 Q4	2/16/2021	693	0.0%	9,467	12/31/2020
2020 Q3	11/13/2020	641	0.0%	8,257	9/30/2020
2020 Q2	8/11/2020	459	0.0%	8,257	6/30/2020
2020 Q1	5/15/2020	275	0.0%	9,300	3/31/2020
2019 Q4	3/18/2020	337	0.0%	9,300	12/31/2019